Thomas Christine E 4
4 · FEMASYS INC · Filed Oct 17, 2022
Insider Transaction Report
Form 4
FEMASYS INCFEMY
Thomas Christine E
Chief Reg & Clinical Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-10-10+50,000→ 50,000 totalExercise: $1.32Exp: 2032-10-10→ Common Stock (50,000 underlying)
Footnotes (1)
- [F1]The shares underlying the stock option vest equally in installments over 4 years beginning on October 10, 2023, provided that the reporting person is employed by the Issuer or a subsidiary of the Issuer on the vesting date.